Abstract
Cigarette smoke (CS) exposure is a key risk factor for both active and latent tuberculosis (TB). It is associated with delayed diagnosis, more severe disease progression, unfavourable treatment outcomes and relapse after treatment. Critically, CS exposure is common in heavily populated areas with a high burden of TB, such as China, India and the Russian Federation. It is therefore prudent to evaluate interventions for TB while taking into account the immunological impacts of CS exposure. This review is a mechanistic examination of how CS exposure impairs innate barrier defences, as well as alveolar macrophage, neutrophil, dendritic cell and T-cell functions, in the context of TB infection and disease.
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine
Reference161 articles.
1. World Health Organization . Global Tuberculosis Report 2020. Geneva, World Health Organization, 2021.
2. The global cost of tuberculosis;Burki;Lancet Respir Med,2018
3. Global Health Observatory . Estimates of Current Tobacco Use, Tobacco Smoking and Cigarette Smoking (Age-standardized). Geneva, World Health Organization, 2018.
4. An Association Between Smoking and Respiratory Tuberculosis
5. Chronic bronchitis, smoking and social class. A study among working people in the towns of Mid and East Cheshire;Rimington;Br J Dis Chest,1969
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献